Home / Resource Library / Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in CanadaOptimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada